Acute Myeloid Leukemia Clinical Trials

A listing of Acute Myeloid Leukemia medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

UPDATED

Duarte California 91010

Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia With an IDH1 and/or IDH2 Mutation

UPDATED

Los Angeles California 90095

Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia With an IDH1 and/or IDH2 Mutation

Colorado

UPDATED

Aurora Colorado 80045

A clinical trial seeking patients for a Cancer treatment research study

UPDATED

Aurora Colorado 80045

Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia With an IDH1 and/or IDH2 Mutation

Illinois

UPDATED

Chicago Illinois 60637

Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia With an IDH1 and/or IDH2 Mutation

Maryland

UPDATED

Baltimore Maryland 21287

Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia With an IDH1 and/or IDH2 Mutation

Massachusetts

UPDATED

Boston Massachusetts 02215

Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia With an IDH1 and/or IDH2 Mutation

New Jersey

UPDATED

Hackensack New Jersey 07601

Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia With an IDH1 and/or IDH2 Mutation

New York

UPDATED

New York New York 10065

A clinical trial seeking patients for a Cancer treatment research study

UPDATED

New York New York 10065

Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia With an IDH1 and/or IDH2 Mutation

Ohio

UPDATED

Columbus Ohio 43210

Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia With an IDH1 and/or IDH2 Mutation

South Carolina

UPDATED

Charleston South Carolina 29425

Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia With an IDH1 and/or IDH2 Mutation

Tennessee

UPDATED

Nashville Tennessee 37232

Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia With an IDH1 and/or IDH2 Mutation

Texas

UPDATED

Dallas Texas 75390

Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia With an IDH1 and/or IDH2 Mutation

UPDATED

Houston Texas 77030

A clinical trial seeking patients for a Cancer treatment research study

UPDATED

Houston Texas 77030

Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia With an IDH1 and/or IDH2 Mutation

Australia

UPDATED

East Melbourne Victoria 3002

A clinical trial seeking patients for a Cancer treatment research study

Belgium

UPDATED

Brugge 8000

A Phase 2 clinical study for patients with Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

UPDATED

Brussels 1000

A Phase 2 clinical study for patients with Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

UPDATED

Leuven 3000

A Phase 2 clinical study for patients with Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

UPDATED

Liège 4000

A Phase 2 clinical study for patients with Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

Canada

UPDATED

Hamilton Ontario L8V 1C3

A Phase 2 clinical study for patients with Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

UPDATED

Montreal Quebec H1T 2M4

A Phase 2 clinical study for patients with Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

Croatia

UPDATED

Zagreb 10000

A Phase 2 clinical study for patients with Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

Germany

UPDATED

Ulm 89081

Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia With an IDH1 and/or IDH2 Mutation

UPDATED

Würzburg 97080

A Phase 2 clinical study for patients with Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

Japan

UPDATED

Fukuoka

A clinical research study of Gilteritinib and Placebo for the treatment of Acute Myeloid Leukemia

UPDATED

Isehara

A clinical research study of Gilteritinib and Placebo for the treatment of Acute Myeloid Leukemia

UPDATED

Kagoshima-shi

A clinical research study of Gilteritinib and Placebo for the treatment of Acute Myeloid Leukemia

UPDATED

Kobe

A clinical research study of Gilteritinib and Placebo for the treatment of Acute Myeloid Leukemia

UPDATED

Kyoto

A clinical research study of Gilteritinib and Placebo for the treatment of Acute Myeloid Leukemia

View More ▼

UPDATED

Nagoya

A clinical research study of Gilteritinib and Placebo for the treatment of Acute Myeloid Leukemia

UPDATED

Nishinomiya

A clinical research study of Gilteritinib and Placebo for the treatment of Acute Myeloid Leukemia

UPDATED

Okayama

A clinical research study of Gilteritinib and Placebo for the treatment of Acute Myeloid Leukemia

UPDATED

Osaka City

A clinical research study of Gilteritinib and Placebo for the treatment of Acute Myeloid Leukemia

UPDATED

Sapporo

A clinical research study of Gilteritinib and Placebo for the treatment of Acute Myeloid Leukemia

UPDATED

Suita

A clinical research study of Gilteritinib and Placebo for the treatment of Acute Myeloid Leukemia

UPDATED

Yokohama

A clinical research study of Gilteritinib and Placebo for the treatment of Acute Myeloid Leukemia

Korea, Republic of

UPDATED

Seoul

A clinical research study of Gilteritinib and Placebo for the treatment of Acute Myeloid Leukemia

UPDATED

Seoul

A clinical research study of Gilteritinib and Placebo for the treatment of Acute Myeloid Leukemia

UPDATED

Seoul

A clinical research study of Gilteritinib and Placebo for the treatment of Acute Myeloid Leukemia

UPDATED

Seoul

A clinical research study of Gilteritinib and Placebo for the treatment of Acute Myeloid Leukemia

UPDATED

Seoul

A clinical research study of Gilteritinib and Placebo for the treatment of Acute Myeloid Leukemia

View More ▼

UPDATED

Seoul 06351

A clinical trial seeking patients for a Cancer treatment research study

Netherlands

UPDATED

Amsterdam 1081 HV

Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia With an IDH1 and/or IDH2 Mutation

UPDATED

Rotterdam 3075 EA

Safety Study of AG-120 or AG-221 in Combination With Induction and Consolidation Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia With an IDH1 and/or IDH2 Mutation

Poland

UPDATED

Warszawa

A clinical research study of Gilteritinib and Placebo for the treatment of Acute Myeloid Leukemia

Portugal

UPDATED

Lisboa 1649-028

A Phase 2 clinical study for patients with Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

Spain

UPDATED

Barcelona 08036

A clinical trial seeking patients for a Cancer treatment research study

UPDATED

Madrid 28040

A clinical trial seeking patients for a Cancer treatment research study